Joseph M. Patti, Chief Scientific Officer at INHIBITEX, INC. (INHX), bought 20,000 shares at $0.22 ($4K) on 2008-11-14, disclosed to the SEC on 2008-11-17.
Open-market purchase of $4k INHX by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BOTA | BUY | 2014-06-30 | $14K | — | Filing → |
| BOTA | BUY | 2014-06-12 | $38K | — | Filing → |
| INHX | SELL | 2011-11-08 | $1.6M | — | Filing → |